NCT01620840View on ClinicalTrials.gov

Lacosamid-i.v.-Register

CompletedOBSERVATIONAL
Enrollment

130

Participants

Timeline

Start Date

June 30, 2011

Primary Completion Date

November 30, 2013

Study Completion Date

November 30, 2013

Conditions
Epilepsy With Partial Onset Seizures With or Without Secondary Generalization
Interventions
DRUG

Lacosamide 10mg/ml

intravenous administration up to 10 days

Trial Locations (1)

24105

Universitätsklinikum Schleswig-Holstein, Campus Kiel, Klinik für Neurologie, Kiel

All Listed Sponsors
lead

University Hospital Schleswig-Holstein

OTHER

NCT01620840 - Lacosamid-i.v.-Register | Biotech Hunter | Biotech Hunter